| dc.contributor.author | Guttieres, Donovan | |
| dc.contributor.author | Diepvens, Charlot | |
| dc.contributor.author | Grais, Rebecca F | |
| dc.contributor.author | Kiarie, Jackline | |
| dc.contributor.author | Vandaele, Nico | |
| dc.contributor.author | Decouttere, Catherine | |
| dc.date.accessioned | 2025-03-14T13:54:31Z | |
| dc.date.available | 2025-03-14T13:54:31Z | |
| dc.date.issued | 2005-02-24 | |
| dc.identifier.citation | Guttieres D, Diepvens C, Grais RF, Kiarie J, Vandaele N, Decouttere C. Charting a novel path towards Ebola virus disease preparedness: Considerations for preventive vaccination. PLoS Med. 2025 Feb 24;22(2):e1004543. doi: 10.1371/journal.pmed.1004543. PMID: 39992920; PMCID: PMC11849863. | en_US |
| dc.identifier.uri | https://repository.amref.ac.ke/handle/20.500.14173/994 | |
| dc.description.abstract | In June 2024, Gavi, the Vaccine Alliance, launched a preventive vaccination program against Ebola virus disease (EVD). This marks a historic shift in the management of EVD, allowing at-risk countries across sub-Saharan Africa to request support in implementing preventive vaccination campaigns. This perspective piece shares considerations that can inform how countries approach preventive EVD vaccination and potential unintended consequences. It also provides insights into strategies for vaccines against other epidemic-prone pathogens.
Copyright: © 2025 Guttieres et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | PLoS Med | en_US |
| dc.subject | Ebola virus disease | en_US |
| dc.subject | preventive vaccination | en_US |
| dc.title | Charting a novel path towards Ebola virus disease preparedness: Considerations for preventive vaccination | en_US |
| dc.type | Article, Journal | en_US |
